Please note

Due to the recent spike in Covid-19 cases, we are no longer able to entertain walk-in visits to our headquarters or any of our facilities.

OMZ delayed-release capsule

Ferron Par Pharmaceuticals

Product packaging may vary from one country to another.

Ingredients in every delayed-release capsule

Omeprazole 20 mg

Each package contains

5 strips of 6 delayed-release capsule

Other details

Dosage formCapsule delayed-release
Flavour None

W.H.O. classification

ATC Level 1 A – Alimentary tract and metabolism
ATC Level 2 A02 – Drugs for Acid Related Disorders
ATC Level 3 A02A – Antacids

Warnings

Pregnancy

<span class="warning-1 warning-pregnancy">CAUTION</span>This item may not be safe for use during pregnancy. Use with caution and after consultation with your doctor.

Lactation

CAUTIONThis item may not be safe for use during lactation. Use with caution and after consultation with your doctor.

Alcohol

CONSULT YOUR DOCTORSafety of this item for use with alcohol has not been established. Please consult your doctor.

Machinery

CAUTIONThis item may not be safe for use while operating heavy machinery. Use with caution and after consultation with your doctor.

Available in

Indonesia

Dosage information

18 YEARS OLD AND ABOVE
Recommended dose:
20 mg or 40 mg once daily, swallowed whole with water.

Omeprazole capsule should be taken before meal. The whole capsules should not be opened, chewed, or crushed and should be swallowed.

— Patients with duodenal ulcer symptoms:
Treatment and healing may take 2 weeks. Patients who have not recovered within this initial treatment, usually require additional 2 weeks of therapy.

— Patients with peptic ulcers or erosive/ulcerative esophagitis reflux symptoms:
Treatment and healing may take 4 weeks. Patients who have not recovered usually require additional 4 weeks of treatment.

— Patients with refractory to other medications:
40 mg once daily and the healing usually attained within 4 weeks (for duodenal ulcer patients) or 8 weeks (for peptic ulcer or erosive/ulcerative esophagitis reflux).

— Patients with Zollinger-Ellison syndrome:
Initial dose is 20-160 mg once daily, the dose should be adjusted individually and treatment should be given as long as clinically indicated. Dose higher than 80 mg per day should be divided, twice daily.

UP TO 18 YEARS
There has been no experience using omeprazole in children.

ELDERLY PATIENTS
No dose adjustment is required.

PATIENTS WITH HEPATIC IMPAIRMENT
No need for special doses.

PATIENTS WITH RENAL IMPAIRMENT
No need for special doses.

Indication

– Short-term treatment of duodenal ulcers and which is unresponsive to H2 receptor antagonist drugs. (I p.3009, 3011; III p.3; IV p.O.17; VI p.2; VII; VIII p.4; IX p.13; X p.2210)

– Short-term treatment of peptic ulcers. (III p.3; IV p.O.17; V p.1; VI p.2; VII; VIII p.4; IX p.1; X p.2210)

– Treatment of erosive/ulcerative esophagitis reflux that has been diagnosed by endoscopy. (I p.3009, 3010; III p.3; IV p.O.17; V p.1, 2; VI p.2; VII; VIII p.4; IX p.13, 14; X p.2210)

– Long-term treatment of Zollinger-Ellison syndrome. (I p.3009, 3011; III p.3; IV p.O.17; V p.2; VI p.2; VII; VIII p.4; IX p.13)